Advantix Spot-On (100 mg + 500 mg)/1 ml; roztwór do nakrapiania
Advantix Spot-On (100 mg + 500 mg)/1 ml; roztwór do nakrapiania
Authorised
This information is not available for this product.
Product identification
Medicine name:
Advantix Spot-On (100 mg + 500 mg)/1 ml; roztwór do nakrapiania
Active substance:
This information is not available for this product.
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
-
All relevant tissuesno withdrawal periodThe withdrawal period does not apply.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AC54
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1412
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?:
